Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

ABIN-2 is required for optimal activation of Erk MAP kinase in innate immune responses

Stamatia Papoutsopoulou, Antony Symons, Tharsana Tharmalingham, Monica P. Belich, Frank Kaiser, Dimitris Kioussis, Anne O'Garra, Victor Tybulewicz, Steven C. Ley*

*Korrespondierende/r Autor/-in für diese Arbeit

Abstract

The TPL-2 MEK kinase is essential for activation of the Erk MAP kinase pathway during innate immune responses. TPL-2 is found in complex with ABIN-2 (A20-binding inhibitor of NF-κB 2). Here, using antigen-presenting cells from ABIN-2-deficient mice, we show that ABIN-2 was required for optimal activation of Erk induced by receptors that signal via TPL-2, including Toll-like receptor 4 and tumor necrosis factor receptor 1 in macrophages, and CD40 in B cells. ABIN-2 was necessary for the maintenance of TPL-2 protein stability. In contrast, ABIN-2 deficiency did not affect agonist-induced regulation of transcription factor NF-κB. Stimulation of ABIN-2-deficient macrophages via Toll-like receptor 4 showed that different thresholds of Erk signaling were required for optimal induction of tumor necrosis factor and interleukin 1β. Thus, ABIN-2 acts to positively regulate the Erk signaling potential by stabilizing TPL-2.

OriginalspracheEnglisch
ZeitschriftNature Immunology
Jahrgang7
Ausgabenummer6
Seiten (von - bis)606-615
Seitenumfang10
ISSN1529-2908
DOIs
PublikationsstatusVeröffentlicht - 06.2006

Fördermittel

We thank T. Kitamura and P. Tsichlis for reagents; S. Beinke and B. Seddon (Division of Immune Cell Biology, NIMR) for critical reading of the manuscript; A. Garefalaki and U. Menzel (Division of Molecular Immunology, NIMR) for help with culturing targeted embryonic stem cells; M. Holman (Division of Immunoregulation, NIMR) for advice on LPS injections; and the NIMR Photographics department, NIMR Biological Services and other members of the Ley laboratory for help during the course of this work. Supported by the UK Medical Research Council and Arthritis Research Campaign (L0549 to A.S. and 16053 to F.K.).

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen

Strategische Forschungsbereiche und Zentren

  • Querschnittsbereich: Medizinische Genetik

Fingerprint

Untersuchen Sie die Forschungsthemen von „ABIN-2 is required for optimal activation of Erk MAP kinase in innate immune responses“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren